SMARCA4 and colonic neoplasm: The BRG1 degrader, AU-15330, demonstrated inhibitory effects on cell invasion across various cancer types, including skin cancer, ccRCC, and colon cancer, without impacting cell proliferation (Fig. 7i and Supplementary Fig. 10l, m).